ask="2.50"
ask_size="1900"
average_daily_volume="543049"
bid="2.30"
bid_size="200"
book_value="1.37"
change="+0.20"
change_from_200_day_moving_average="-0.66"
change_from_50_day_moving_average="-0.04"
change_from_52_week_high="-6.40"
change_From_52_week_low="0.38"
change_in_percent="+8.70%"
close="2.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.31"
ebitda="-61.52M"
eps_estimate_current_year="-1.55"
eps_estimate_next_quarter="-0.38"
eps_estimate_next_year="-1.42"
ex_dividend_date="N/A"
float_shares="36032000"
high="2.50"
high_52_weeks="8.90"
last_trade_date="1/4/2017"
last_trade_price="2.50"
last_trade_size="16581"
last_trade_time="4:00pm"
low="2.33"
low_52_weeks="2.12"
market_capitalization="132.31M"
moving_average_200_day="3.16"
moving_average_50_day="2.54"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="8.60"
open="2.35"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="-20.97%"
percent_change_from_50_day_moving_average="-1.59%"
percent_change_from_52_week_high="-71.91%"
percent_change_from_52_week_low="+17.65%"
previous_close="2.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.68"
price_per_sales="10.11"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="6.08"
stock_exchange="NGM"
symbol="RGLS"
volume="773050"
weeks_range_52="2.12 - 8.90"
